Skip to main content

Main menu

  • About Us
    • Leadership
    • Our Team
    • Vision, Mission and Values
    • Health and Economic Impact
    • Research Impact Video
    • Strategic Plan
  • Our Research
    • Research Focus
      • Brain Health
      • Cancer
      • Digital Health and Artificial Intelligence
      • Heart Health
      • Healthy Aging and Mobility
      • Immune System
      • Injury and Rehabilitation
      • Lung Health
      • Mental Health and Substance Use
    • Research Centres and Programs
      • BC Centre on Substance Use
      • Centre for Aging SMART
      • Centre for Cardiovascular Innovation
      • Centre for Clinical Epidemiology and Evaluation
      • Centre for Lung Health
      • Djavad Mowafaghian Centre for Brain Health
      • Immunity and Infection Research Centre
      • International Collaboration On Repair Discoveries
      • M. H. Mohseni Institute of Urologic Sciences
      • Ovarian Cancer Research Centre
      • Community Research Program
      • Emergency Medicine Research Program
      • Hematology Research Program
      • Skin Research Program
      • Other Research Focus Areas
    • News and Stories
    • Researcher Directory
    • Events and Workshops
  • Research Services
    • New to VCHRI
      • Working at VCHRI
      • Regulations and Training
      • Membership with VCHRI
      • Learning and Development
    • Starting Your Project
      • Research Facilitation
      • Awards and Funding
      • Grant Management
      • Operational Approval
      • CST Cerner
    • Developing Your Project
      • Clinical Trials Administration
      • Clinical Research Unit
      • Research Privacy
      • Financial Policies and Procedures
    • Additional Support
      • Indigenous Health Research Unit
      • VCH-VCHRI AI Hub
      • Communications and Media Relations
      • Study Recruitment Support
      • Innovation and Industry Partnership
    • Internal Awards
    • Clinical Research
    • Indigenous Research
  • Participate in Research
    • Reasons to Participate
    • Participant Stories
    • Find a Study
    • Recruitment Support

User menu

  • Log in

Breadcrumb

  1. Home
  2. Our Research
  3. News and Stories
  4. Tuberculosis continues to be the smartest simple bug

Tuberculosis continues to be the smartest simple bug

Stories Oct 16, 2014 2 minutes

Infection without symptoms fuels TB’s proliferation in developing countries.

Although one-third of the world has been exposed to the bacteria that causes tuberculosis (TB), and many millions of people carry a dormant version of TB, only a very small percentage of them succumb to the disease. Still, in 2012, that small percentage equaled a staggering 1.3 million deaths1, mostly in developing countries.

“It fascinates me how a microbe can survive and infect human beings so successfully – and the best way it does this is by not killing the majority of people it infects,” says Vancouver Coastal Health Research Institute researcher, Dr. Yossef Av-Gay, professor at the Infection and Immunity Research Centre. “If people died immediately from TB, it would have wiped out a large percentage of the world’s population and then disappeared.”

Dr. Av-Gay’s interest in TB can be seen in his more than 20 years researching Mycobacterium tuberculosis (M. tuberculosis), the bacteria that causes the airborne disease. He is currently leading collaboration between academia and pharmaceutical companies studying the biology of M. tuberculosis, and particularly mechanisms that this bug uses to subvert our immune response.

“We’re looking to discover weak points of the bug,” Dr. Av-Gay explains. “And these weak points are targets for drug therapy.”

The co-existence of bacteria and human being and interaction between host and pathogen interested Dr. Av-Gay when he first started studying biology. His research laboratory uses combined biochemical, genetic, and immunological approaches to study proteins in detail, focusing on their role in tuberculosis pathogenesis. His work has shown that certain proteins are key modulators of successful M. tuberculosis infection of human macrophages, which are large, specialized cells of the immune system that are formed in response to an infection or accumulating damaged or dead cells.

​“How smart it is that a simple bug would to do such complicated maneuvers to survive inside out,” he says. 

“The majority of people who get infected don’t show any signs of the disease,” says Dr. Av-Gay. “That’s one of the areas that we study: how TB can so elegantly stay undetected in so many people.”

Members of Dr. Av-Gay’s research team are currently working in Spain and South Africa, and Dr. Av-Gay himself is training researchers and microbiologists in Romania, all in an effort to develop better methods and drugs to counteract the disease.

 

 1http://www.who.int/mediacentre/factsheets/fs104/en/

Share:

  • Facebook
  • Linkedin
  • Twitter
  • Email

Related Research Centres/Programs

Immunity and Infection Research Centre

Get the latest research headlines in your inbox

Subscribe

Recent News and Stories

Type
Announcement

Investigator Awards 2025 Recipients

Apr 29, 2025 award
Type
Stories

Ask an expert: What should I know about kidney stones?

Apr 23, 2025 kidney, treatment options
Type
Stories

New solution to treat obstructive sleep apnea

Apr 22, 2025 sleep, treatment options
See more news

Get updates!

Join our newsletter mailing list to stay up to date on features and releases.

Subscribe

Quick Links

  • News and Stories
  • Careers
  • Events
  • Media Enquiries

Follow Us

  • LinkedIn
  • X
  • YouTube

© 2025 VCHRI. All rights reserved.

  • Contact
  • Privacy Policy